2019 • 2018 • 2017 • 2016 • 2015 • 2014 • 2013 • 2012 • 2011 • 2010
2009 • 2008 • 2007 • 2006 • 2005 • 2004 • 2003 • 2002 • 2001 • 2000
— 2010 —
Akhvlediani T; Clark DV; Chubabria G; Zenaishvili O; Hepburn MJ. The changing pattern of human brucellosis: Clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. BMC Infectious Diseases 2010; 10: 346
Alkhalil A, Hammamieh R, Hardick J, Ichou MA, Jett M, Ibrahim S. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions. Virology Journal 2010 Jul, 7: 173
Allton DR; Rivard RG; Connolly PA; McCall S; Durkin MM; Boyd TM; Flanagan JP; Wheat LJ; Hospenthal DR. Detection of Latin American strains of Histoplasma in a murine model by use of a commercially available antigen test. Clinical and Vaccine Immunology 2010 May; 17(5): 802-6
Alves DA; Bell TM; Benton C; Rushing EJ; Stevens EL. Giant Thoracic Schwannoma in a Rhesus Macaque (Macaca mulatta). Journal of the American Association for Laboratory Animal Science 2010; 49(6): 868-72
Alves DA, Glynn AR, Steele KE, Lackemeyer MG, Garza NL, Buck JG, Mech C, Reed DS. Aerosol exposure to the angola strain of Marburg virus causes lethal viral Hemorrhagic Fever in cynomolgus macaques. Veterinary Pathology 2010 Sept, 47(5): 831-851
Andrews GP; Vernati G; Ulrich R; Rocke TE; Edwards WH; Adamovicz JJ. Identification of in vivo-induced conserved sequences from Yersinia pestis during experimental plague infection in the rabbit. Vector-Borne Zoonotic Diseases 2010 Oct; 10(8): 749-56
Beitzel BF, Bakken RR, Smith JM, Schmaljohn CS. High-resolution functional mapping of the venezuelan equine encephalitis virus genome by insertional mutagenesis and massively parallel sequencing. PLoS Pathogens 2010 Oct, 6(10):e1001146
Bhattacharyya S; Warfield KL; Ruthel G; Bavari S; Aman MJ; Hope TJ. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 2010 May 25; 401(1): 18-28
Bishop-Lilly KA; Turell MJ; Willner KM; Butani A; Nolan NME; Lentz SM; Akmal A; Mateczun A; Brahmbhatt TN; Sozhamannan S; Whitehouse CA; Read TD. Arbovirus detection in insect vectors by rapid, high-throughput pyrosequencing. PLOS Neglected Tropical Diseases 2010 Nov; 4(11): e878
Bradfute SB; Swanson PE; Smith MA; Watanabe E; McDunn JE; Hotchkiss RS; Bavari S. Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis. Journal of Immunology Jan 1 2010, 184(1): 327-35
Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virology Journal 2010; 7: 279
Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virology Journal 2010; 7: 306
Burke RL; West MW; Erwin-Cohen R; Selby EB; Fisher DE; Twenhafel NA. Alterations in cytokines and effects of dexamethasone immunosuppression during subclinical infections of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques. Comparative Medicine 2010, 60(1): 62-70
Burnett JC; Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir D; Bavari S; Bowlin T. Analysis of botulinum neurotoxin serotype A metalloprotease inhibitors: Analogs of a chemotype for therapeutic development in the context of a three-zone pharmacophore. Open Access Bioinformatics 2010 Apr 1; 2010(2): 11-18
Burtnick MN; DeShazer D; Nair V; Gherardini FC; Brett PJ. Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infection and Immunity 2010 Jan; 78(1): 88-99
Butler MM; Williams JD; Peet NP; Moir DT; Panchal RG; Bavari S; Shinabarger DL; Bowlin TL. Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates. Antimicrobial Agents Chemotherapy 2010 Sept; 54(9): 3974-7
Chapman JL, Nichols DK, Martinez MJ, Raymond JW. Animal models of orthopoxvirus infection. Veterinary Pathology 2010 Sept, 47(5): 852-870
Dembek, Z. World-class chem-bio training offered at USAMRIID and USAMRICD. Force Health Protection and Readiness 2010, 5(1): 10
Dabisch PA; Kline J; Lewis C; Yeager J; Pitt MLM. Characterization of a head-only aerosol exposure system for nonhuman primates. Inhalation Toxicology Feb 2010, 22(3): 224-33
Diniz PP; Beall MJ; Omark K; Chandrashekar R; Daniluk DA; Cyr KE; Koterski JF; Robbins RG; Lalo PG; Hegarty BC; Breitschwerdt EB. High prevalence of tick-borne pathogens in dogs from an Indian reservation in northeastern Arizona. Vector-Borne and Zoonotic Diseases 2010 Mar; 10(2): 117-23
Do Y; Koh H; Park CG; Dudziak D; Seo P; Mehandru S; Choi JH; Cheong C; Park S; Perlin DS; Powell BS; Steinman RM. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. European Journal Immunology 2010 Oct; 40(10): 2791-6
Drozdowski B; Zhou Y; Kline B; Spidel J; Chan YY; Albone E; Turchin H; Chao Q; Henry M; Balogach J; Routhier E; Bavari S; Nicolaides NC; Sass PM; Grasso L. Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B. Journal of Immune Based Therapies and Vaccines 2010 Dec 21; 8: 9
Dupuy LC, Richards MJ, Reed DS, Schmaljohn CS. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates. Vaccine Oct 28 2010, 28(46): 7345-50
Eppinger M; Worsham PL; Nikolich MP; Riley DR; Sebastian Y; Mou S; Achtman M; Lindler LE; Ravel J. Genome sequence of the deep-rooted yersinia pestis strain Angola reveals new insights into the evolution and pangenome of the plague bacterium. Journal Bacteriology 2010 Mar; 192(6): 1685-99
Farlow J; Ichou MA; Huggins J; Ibrahim S. Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus. Virology Journal 2010 May, 7: 110
Fellows P; Adamovicz J; Hartings J; Sherwood R; Mega W; Brasel T; Barr E; Holland L; Lin W; Rom A; Blackwelder W; Price J; Morris S; Snow D; Hart MK. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V). Vaccine 2010 Nov 16; 28(49): 7748-56
Felts RL; Narayan K; Estes JD; Shi D; Trubey CM; Fu J; Hartnell LM; Ruthel GT; Schneider DK; Nagashima K; Bess Jr. JW; Bavari S; Lowekamp BC; Bliss D; Lifson JD; Subramaniam S. 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proceedings of the National Academy of Sciences USA 2010 July 27; 107(30): 13336-41
Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV). Journal of Virological Methods 2010 Feb, 163(2): 424-32
Galyov EE; Brett PJ; Deshazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annual Review of Microbiology 2010; 64: 495-517
Geisbert TW; Bailey M; Geisbert JB; Asiedu C; Roederer M; Grazia-Pau M; Custers J; Jahrling P; Goudsmit J; Koup R; Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. Journal of Virology Oct 2010, 84(19): 10386-94
Geisbert TW; Daddario-Dicaprio KM; Hickey AC; Smith MA; Chan YP; Wang LF; Mattapallil JJ; Geisbert JB; Bossart KN; Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLOS One 2010; 5(5): e10690
Geisbert TW; Hensley LE; Geisbert JB; Leung A; Johnson JC; Grolla A; Feldmann H. Postexposure treatment of Marburg virus infection. Emerging Infectious Diseases 2010 July; 16(7): 1119-22
Geisbert TW; Lee AC; Robbins M; Geisbert JB; Honko AN; Sood V; Johnson JC; de Jong S; Tavakoli I; Judge A; Hensley LE; MacLachlan I. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet 2010 May 29; 375(9729): 1896-905
Gill SC; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Beaudry A; Li J; Stone KC; Critchley I; Janjic N; Heine HS. Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model. Antimicrobial Agents Chemotherapy 2010 May; 54(5): 1678-83
Golden JW; Hooper JW. Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model. Clinical and Vaccine Immunology 2010 Nov, 17(11): 1656-65
Grant RJ; Baldwin CD; Nalca A; Zoll S; Blyn LB; Eshoo MW; Matthews H; Sampath R; Whitehouse CA. Application of the Ibis-T5000 pan-Orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus. American Journal of Tropical Medicine and Hygiene Feb 2010, 82(2): 318-23
Grant-Klein RJ; Baldwin CD; Turell MJ; Rossi Cynthia A; Li F; Lovari R; Crowder CD; Matthews HE; Rounds MA; Eshoo MW; Blyn LB; Ecker DJ; Sampath R; Whitehouse CA. Rapid identification of vector-borne flaviviruses by mass spectrometry. Molecular and Cellular Probes Aug 2010, 24 (4): 219-28
Grim CJ; Jaiani E; Whitehouse CA; Janelidze N; Kokashvili T; Tediashvili M; Colwell RR; Huq A. Detection of toxigenic vibrio cholerae O1 in freshwater lakes of the former Soviet Republic of Georgia. Environmental Microbiology Reports 2010 Feb; 2(1): 2-6
Gul N; Smith LA; Ahmed SA. Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form. PloS One 2010 Sept, 5(9): e12872
Guntur VP; Waldrep JC; Guo JJ; Selting K; Dhand R. Increasing P53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro. Anticancer Research 2010 Sept; 30(9): 3557-64
Hakami RM; Ruthel G; Stahl AM; Bavari S. Gaining ground: Assays for therapeutics against botulinum neurotoxin. Trends in Microbiology 2010 Apr; 18(4): 164-72
Heine HS; Bassett J; Miller L; Purcell BK; Byrne WR. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation. Antimicrobial Agents and Chemotherapy Oct 2010, 54(10): 4471-3
Heine HS; Miller L; Halasohoris S; Holman K; Zadeh M. Assessment of Burkholderia Pseudomallei (bp) In Vitro Susceptibility and Efficacy in a Murine-Aerosol Challenge Model for Five Antibiotic Classes. 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 12 -15, 2009, 49: 54
Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP. Activity of Dalbavancin against Bacillus anthracis In Vitro and in a Mouse Inhalation Anthrax Model. Antimicrobial Agents and Chemotherapy Mar 2010, 54(3): 991-6
Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ. Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog May 2010, 6(5):pe1000904
Hill BJ; Skerry JC; Smith TJ; Arnon SS; Douek DC. Universal and specific quantitative detection of botulinum neurotoxin genes. BMC Microbiology 2010; 10: 267
Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR. Extraction of BoNT/A, /B, /E, and /F with a single; high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLOS One 2010; 5(8): e12237
Keasey S; Pugh C; Tikhonov A; Chen G; Schweitzer B; Nalca A; Ulrich RG. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLOS One 2010; 5(12): e15547
Kim HC; Lee IY; Chong ST; Richards AL; Gu SH; Song JW; Lee JS; Klein TA.. Serosurveillance of scrub typhus in small mammals collected from military training sites near the DMZ, Northern Gyeonggi-do, Korea;,and analysis of the relative abundance of chiggers from mammals examined. Korean Journal of Parasitology 2010 Sept; 48(3): 237-43
Kissner TL; Cisney ED; Ulrich RG; Fernandez S; Saikh KU. Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88. Immunology 2010 Aug, 130(4): 516-26
Krakauer T. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock. Toxins 2010 Aug; 2(8): 1963-83
Krakauer T; Buckley M; Issaq HJ; Fox SD. Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo. Antimicrobial Agents and Chemotherapy Mar 2010, 54(3): 1125-31
Krakauer T; Buckley M; Fisher D. Murine models of staphylococcal enterotoxin B-induced toxic shock. Military Medicine 2010 Nov, 175(11): 917-22
Krakauer T; Buckley M; Fisher D. Proinflammatory mediators of toxic shock and their correlation to lethality. Mediators of Inflammation 2010: 517594
Kranzusch PJ; Schenk AD; Rahmeh AA; Radoshitzky SR; Bavari S; Walz T; Whelan SPJ. Assembly of a functional Machupo virus polymerase complex. Proceedings of the National Academy of Science USA 2010 Nov 16; 107(46): 20069-74
Larkin EA; Stiles BG; Ulrich RG. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PloS One 2010, 5(10): pe13253
Lee MS; Olson MA. Protein folding simulations combining self-guided langevin dynamics and temperature-based replica exchange. Journal of Chemical Theory and Computation 2010 Aug 10; 6(8): 2477-87
Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir DT; Bavari S; Bowlin TL. Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors. Journal of Medicinal Chemistry 2010 Mar 11; 53(5): 2264-76
Lin J; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 2010 Dec 16; 29(2): 357-62
Little SF; Webster WM; Wilhelm H; Fisher D; Norris SLW; Powell BS; Enama J; Adamovicz JJ. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice. Vaccine Jan 22 2010, 28(4): 934-9
Liu F; Hakami RM; Dyas B; Bahta M; Lountos GT; Waugh DS; Ulrich RG; Burke Jr. TR. A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase; YopH. Bioorganic and Medicinal Chemistry Letters 2010 May 1; 20(9): 2813-6
Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 2010 Jan 22; 28(4): 1056-61
Losada L; Ronningf CM; Deshazer D; Woods D; Fedorova N; Kim HS; Shabalina SA; Pearson TR; Brinkac L; Tan P; Nandi T; Crabtree J; Badger J; Beckstrom-Sternberg S; Saqib M; Schutzer SE; Keim P; Nierman WC. Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements. Genome Biology and Evolution 2010; 2(1): 102-16
Lou J; Geren I; Garcia-Rodriguez C; Forsyth C M; Wen W; Knopp K; Brown J; Smith T; Smith LA; Marks JD. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Engineering Design & Selection 2010 Apr, 23(4): 311-319
Loveless BM; Yermakova A; Christensen DR; Kondig JP; Heine HS; Wasieloski LP; Kulesh DA. Identification of ciprofloxacin resistance by SimpleProbe, High Resolution Melt and Pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis. Molecular and Cellular Probes Jun 2010, 24(3): 154-60
Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Vaccine 2010 Jan 22, 28(4): 1031-40
Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus. Vaccine 2010 Apr 19, 28(18): 3143-51
Martinez O; Johnson J; Manicassamy B; Rong L; Olinger GG; Hensley LE; Basler CF. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology 2010; 12(2): 148-57
Matchett MR; Biggins DE; Carlson V; Powell B; Rocke T. Enzootic plague reduces black-footed ferret (Mustela Nigripes) survival in Montana. Vector-Borne and Zoonotic Diseases 2010 Jan/Feb; 10(1): 27-35
McGann P; Rozak DA; Nikolich MP; Bowden RA; Lindler LE; Wolcott MJ; Lathigra R. A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes. Journal of Microbiological Methods 2010 Feb; 80(2): 164-171
Michelow IC; Dong M; Mungall BA; Yantosca LM; Lear C; Ji X; Karpel M; Rootes CL; Brudner M; Houen G; Eisen DP; Kinane TB; Takahashi K; Stahl GL; Olinger GG; Spear GT; Ezekowitz RAB; Schmidt EV. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. Journal of Biological Chemistry 2010 Aug 6; 285(32): 24729-39
Mitchell JL; Chatwell N; Christensen D; Diaper H; Minogue TD; Parsons TM; Walker B; Weller SA. Development of real-time PCR assays for the specific detection of Francisella tularensis ssp. tularensis; holarctica and mediaasiatica. Molecular and Cellular Probes 2010 Apr; 24(2): 72-6
Mokrievich AN, Kondakova AN, Valade E, Platonov ME, Vakhrameeva GM, Shaikhutdinova RZ, Mironova RI, Blaha D, Bakhteeva IV, Titareva GM, Kravchenko TB, Kombarova TI, Vidal D, Pavlov VM, Lindner B, Dyatlov IA, Knirel YA. �Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC. �Biochemistry (Moscow) Apr 2010, 75 (4): p443-451
Moody KL; Driks A; Rother GL; Cote CK; Brueggemann EE; Hines HB; Friedlander AM; Bozue J. Processing, assembly and localization of a Bacillus anthracis spore protein. Microbiology Jan 2010, 156(Pt 1): 174-83
Nalca A, Livingston VA, Garza NL, Zumbrun EE, Frick OM, Chapman JL, Hartings JM. Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus. PloS One 2010 Sept, 5(9). Pii: e12880
Nalca A, Zumbrun EE. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Design, Development and Therapy 2010 May, 4: 71-9
Natesan M; Ulrich RG. Protein microarrays and biomarkers of infectious disease. International Journal of Molecular Sciences 2010 Dec; 11(12): 5165-83
Nuss JE; Dong Y; Wanner LM; Ruthel G; Wipf P; Gussio R; Vennerstrom JL; Bavari S; Burnett JC. Pharmacophore Refinement Guides the Design of Nanomolar-Range Botulinum Neurotoxin Serotype A Light Chain Inhibitors. ACS Medicinal Chemistry Letters 2010 Oct, 1(7): 301-305
Nuss JE; Ruthel G; Tressler LE; Wanner LM; Torres-Melendez E; Hale ML; Bavari S. Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies. Journal of Biomolecular Screening 2010 Jan, 15(1): 42-51
Nuss JE; Wanner LM; Tressler LE; Bavari S. The osmolyte trimethylamine N-oxide (TMAO) increases the proteolytic activity of botulinum neurotoxin light chains A, B, and E: implications for enhancing analytical assay sensitivity. Journal of Biomolecular Screening 2010 Sep, 15(8): 928-36
O'Guinn ML, Klein TA, Lee JS, Richards AL, Kim Heung-Chul, Ha Si Jung, Shim So Hee, Baek Luck Ju, Song Ki-Joon, Chong Sung-Tae, Turell MJ, Burkett DA, Schuster A, Lee In-Yong, Yi Suk-Hee, Sames WJ, Song Jin-Won. Serological surveillance of scrub typhus, murine typhus, and leptospirosis in small mammals captured at firing points 10 and 60, Gyeonggi province, republic of Korea, 2001-2005. Vector Borne and Zoonotic Diseases Mar 2010, 10(2): 125-33
Opperman TJ; Williams JD; Houseweart C; Panchal RG; Bavari S; Peet NP; Moir DT; Bowlin TL. Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR. Bioorganic and Medicinal Chemistry 2010 Mar 15; 18(6): 2123-30
Ozkaya E; Dincer E; Carhan A; Uyar Y; Ertek M; Whitehouse CA; Ozkul A. Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: Occurrence of local topotype. Virus Research 2010 Apr; 149(1): 64-70
Panchal RG, Kota KP, Spurgers KB, Ruthel G, Tran JP, Boltz RCD, Bavari S. Development of high-content imaging assays for lethal viral pathogens. Journal of Biomolecular Screening Aug 2010, 15(7): 755-65
Pang YP; Davis J; Wang S; Park JG; Nambiar MP; Schmidt JJ; Millard CB. Small molecules showing significant protection of mice against botulinum neurotoxin serotype A. PLOS One 2010; 5(4): e10129
Paranavitana C; Zelazowska E; Dasilva L; Pittman PR; Nikolich M. Th17 cytokines in recall responses against Francisella tularensis in humans. Journal of Interferon and Cytokine Research 2010 July; 30(7): 471-6
Parker MD; Buckley MJ; Melanson VR; Glass PJ; Norwood D; Hart MK. Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection. Journal of Virology 2010 Dec, 84(24): 12683-90
Popova TG; Turell MJ; Espina V; Kehn-Hall K; Kidd J; Narayanan A; Liotta L; Petricoin EF; Kashanchi F; Bailey C; Popov SG. Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift Valley fever virus in human small airway epithelial cells. PLOS One 2010; 5(11): e13805
Pratt WD, Wang D, Nichols DK, Luo M, Woraratanadharm J, Dye JM, Holman DH, Dong JY. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector. Clinical and Vaccine Immunology Apr 2010, 17(4): 572-81
Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, Kuhn JH, Sandwick S, Ruthel G, Kota K, Boltz D, Warren T, Kranzusch PJ, Whelan SPJ, Bavari S. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. Journal of Virology Oct 2010, 84(20): 10569-80
Ray N; Whidby J; Stewart S; Hooper JW; Bertolotti-Ciarlet A. Study of Andes virus entry and neutralization using a pseudovirion system. Journal of Virological Methods 2010 Feb; 163(2): 416-23
Reisler RB, Danner DK, Gibbs PH. Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity. Vaccine Mar 11 2010, 28(12): 2436-41
Ritchie G; Harvey DJ; Stroeher U; Feldmann F; Feldmann H; Wahl-Jensen V; Royle L; Dwek RA; Rudd PM. Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2010 Mar 15; 24(5): 571-85
Rocke TE; Pussini N; Smith SR; Williamson J; Powell B; Osorio JE. Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus). Vector-Borne and Zoonotic Diseases 2010 Jan/Feb; 10(1): 53-8
Ronning CM, Losada L, Brinkac L, Inman J, Ulrich RL, Schell M, Nierman WC, DeShazer D. Genetic and phenotypic diversity in Burkholderia: contributions by prophage and phage-like elements. BMC Microbiology Jul 28 2010, 10: 202
Rooijakkers SHM; Rasmussen SL; McGillivray SM; Bartnikas TB; Mason AB; Friedlander AM; Nizet V. Human transferrin confers serum resistance against Bacillus anthracis. Journal of Biological Chemistry 2010 Sept 3; 285(36): 27609-13
Rowe B, Schmidt JJ, Smith LA, Ahmed SA. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity. Analytical Biochemistry Jan 15 2010, 396(2): 188-93
Rozak DA, Gelhaus HC, Smith M, Zadeh M, Huzella L, Waag D, Adamovicz JJ. CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols. Journal of Immune Based Therapies and Vaccines 2010, 8(1): 2
Sanders JL; Lawrence C; Nichols DK; Brubaker JF; Peterson TS; Murray KN; Kent ML. Pleistophora hyphessobryconis (Microsporidia)infecting zebrafish Danio rerio in research facilities. Diseases of Aquatic Organisms 2010; 91(1): 47-56
Sang R; Kioko E; Lutomiah J; Warigia M; Ochieng C; O'Guinn M; Lee JS; Koka H; Godsey M; Hoel D; Hanafi H; Miller B; Schnabel D; Breiman RF; Richardson J. Rift Valley fever virus epidemic in Kenya, 2006/2007: The entomologic investigations. American Journal of Tropical Medicine and Hygiene 2010 Aug; 83(2 Suppl.): 28-37
Scorpio A; Chabot DJ; Day WA; Hoover TA; Friedlander AM. Capsule depolymerase overexpression reduces Bacillus anthracis virulence. Microbiology 2010 May, 156(Pt 5): 1459-67
Smith DR, McCarthy S, Chrovian A, Olinger G, Stossel A, Geisbert TW, Hensley LE, Connor JH. Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Research Aug 2010, 87(2): 187-94
Smith DR; Ogg M; Garrison A; Yunus A; Honko A; Johnson J; Olinger G; Hensley LE; Kinch MS. Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae. Virus Adaptation and Treatment 2010; 2(1): 9-20
Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE. The pathogenesis of Rift Valley fever virus in the mouse model. Virology Nov 25 2010, 407(2): 256-67
Sobocinski GP; Toy K; Bobrowski WF; Shaw S; Anderson AO; Kaldjian EP. Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: Evidence supporting the reticular network as a pathway for lymphocyte migration. BMC Immunology 2010; 11: 42
Song H; Hwang J; Yi H; Ulrich RL; Yu Y; Nierman WC; Kim HS. The early stage of bacterial genome-reductive evolution in the host. PLOS Pathogens 2010; 6(5): e1000922
Spurgers KB; Alefantis T; Peyser BD; Ruthel GT; Bergeron AA; Costantino JA; Enterlein S; Kota KP; Boltz RCD; Aman MJ; Delvecchio VG; Bavari S. Identification of Essential Filovirion-associated Host Factors by Serial Proteomic Analysis and RNAi Screen. Molecular & Cellular Proteomics 2010 Dec, 9(12): 2690-703
Steele KE. Guest editorial: Special focus on the pathology of biological select agents and toxins in animals and research challenges in biological defense. Veterinary Pathology 2010 Sept, 47(5): 772-773
Steele KE, Twenhafel NA. Review Paper: Pathology of animal models of alphavirus encephalitis. Veterinary Pathology 2010 Sept, 47(5): 790-805
Terra JK; Cote CK; France B; Jenkins AL; Bozue JA; Welkos SL; LeVine SM; Bradley KA. Cutting Edge: Resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. Journal of Immunology 2010 Jan 1; 184(1): 17-20
Thompson J; Hill KK; Smith TJ; Pikis A. The gene CBO0515 from Clostridium botulinum strain Hall A encodes the rare enzyme N5-(carboxyethyl) ornithine synthase, EC 1.5.1.24. Journal of Bacteriology 2010 Feb; 192(4): 1151-55
Tribble DR; Baqar S; Scott DA; Oplinger ML; Trespalacios F; Rollins D; Walker RI; Clements JD; Walz S; Gibbs P; Burg III EF; Moran AP; Applebee L; Bourgeois AL. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infection and Immunity 2010 Apr; 78(4): 1750-9
Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, Kulesh DA. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. May 2010, 82(5):954-60
Turell MJ, Wilson WC, Bennett KE. Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus. Journal of Medical Entomology Sep 2010, 47(5): 884-9
Turell MJ; Dohm DJ; Geden CJ; Hogsette JA; Linthicum KJ. Potential for stable flies and house flies (Diptera: Muscidae) to transmit Rift Valley fever virus. Journal of the American Mosquito Control Association 2010 Dec; 26(4): 445-48
Twenhafel NA. Pathology of inhalational anthrax animal model. Veterinary Pathology 2010 Sept, 47(5): 819-830
Vilensky JA; Gilman S; McCall S. A historical analysis of the relationship between encephalitis lethargica and postencephalitic Parkinsonism: A complex rather than a direct relationship. Movement Disorders 2010 July 15; 25(9): 1116-23
Vilensky JA; Gilman S; McCall S. Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic Parkinsonism? Movement Disorders 2010 July 15; 25(9): 1124-30
Walters MS, Mobley HL. Bacterial proteomics and identification of potential vaccine targets. Expert Rev Proteomics. Apr 2010, 7(2):181-4
Warren TK, Warfield KL, Wells J, Enterlein S, Smith M, Ruthel G, Yunus AS, Kinch MS, Goldblatt M, Aman MJ, Bavari S. Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrobial Agents and Chemotherapy May 2010, 54(5): 2152-9
Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, Nichols DK, Iversen PL, Bavari S. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nature Medicine Sep 2010, 16(9): 991-4
Warren TK, Warfield KL, Wells J, Swenson D, Lovejoy C, Iversen P, Bavari S. Treatment of highly pathogenic filovirus infections using advanced antisense technology. Retrovirology May 11 2010, 7(Suppl. 1): 16-17
Weiner DB; Sardesai NY; Schmaljohn C. Introduction to DNA vaccines - Las Vegas. Vaccine 2010 Feb 23; 28(8): 1893-6
West GF, Lillibridge SR, Howard RJ, Grabenstein J, Dembek ZF, Dombrowski PA. Federal Practitioner 2010 Apr, 27(Suppl 2): 4-10
Whitehouse CA, Baldwin C, Sampath R, Blyn LB, Melton R, Li F, Hall TA, Harpin V, Matthews H, Tediashvili M, Jaiani E, Kokashvili T, Janelidze N, Grim C, Colwell RR, Huq A. Identification of pathogenic Vibrio species by multilocus PCR-electrospray ionization mass spectrometry and its application to aquatic environments of the former soviet republic of Georgia. Applied and Environmental Microbiology Mar 2010, 76(6): 1996-2001
Whitehouse CA, Keirstead N, Taylor J, Reinhardt JL, Beierschmitt A. Prevalence of hypermucoid Klebsiella pneumoniae among wild-caught and captive vervet monkeys (Chlorocebus aethiops sabaeus) on the island of St. Kitts. Journal of Wildlife Diseases Jul 2010, 46(3): 971-6
Wojciechowski J; Chase-Baldwin K; Wasieloski LP; Padilla S; Vora GJ; Taitt CR. Enhancement of deoxyribonucleic acid microarray performance using post-hybridization signal amplification. Analytica Chim Acta 2010 Oct 29; 679(1-2): 85-90
Wolf MC; Freiberg AN; Zhang T; Akyol-Ataman Z; Grock A; Hong PW; Li J; Watson NF; Fang AQ; Aguilar HC; Porotto M; Honko AN; Damoiseaux R; Miller JP; Woodson SE; Chantasirivisal S; Fontanes V; Negrete OA; Krogstad P; Dasgupta A; Moscona A; Hensley LE; Whelan SP; Faull KF; Holbrook MR; Jung ME; Lee B. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences USA 2010 Feb 16; 107(7): 3157-62
Xiao X; Zhu Z; Dankmeyer JL; Wormald MM; Fast RL; Worsham PL; Cote CK; Amemiya K; Dimitrov DS. Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model. PloS One 2010, 5(10): pe13047
Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt MLM. Aerosolized Bacillus anthracis infection in New Zealand White Rabbits: Natural history and intravenous levofloxacin treatment. Comparative Medicine 2010; 60(6): 461-8
Yingst SL, Huzella LM, Chuvala L, Wolcott M. A rhesus macaque (Macaca mulatta) model of aerosol-exposure brucellosis (Brucella suis): pathology and diagnostic implications. J Med Microbiol (England) 2010 Jun, 59(Pt 6):724-30
Zakhashvili K; Tsertsvadze N; Chikviladze T; Jghenti E; Bekaia M; Kuchuloria T; Hepburn MJ; Imnadze P; Nanuashvili A. Crimean-Congo hemorrhagic fever in man, Republic of Georgia, 2009. Emerging Infectious Diseases 2010 Aug; 16(8): 1326-8
Zuniga JE; Hammill JT; Drory O; Nuss JE; Burnett JC; Gussio R; Wipf P; Bavari S; Brunger AT. Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A. PLOS One 2010; 5(6): e11378
|
SITEMAP
ARMY.MIL 
